ArticleBMJ open2026
Non-pharmacological interventions for managing fatigue across the lifespan of people living with chronic musculoskeletal conditions: a scoping review.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesFatigue is an important and distressing symptom for many people living with chronic musculoskeletal (MSK) conditions. Non-pharmacological interventions designed to reduce fatigue have been investigated but the evidence is disparate across MSK conditions and across the lifespan. This scoping review aimed to create an overview of the current knowledge of non-pharmacological interventions for fatigue in MSK conditions across the lifespan, including their theoretical bases, the characteristics of participants and the clinical competencies of those delivering interventions. It aimed to use these findings to identify priorities for research and practice in collaboration with patient and public involvement groups.
designA scoping review following the Joanna Briggs Institute methodology. DATA SOURCES: AMED, MEDLINE, PsycINFO, CINAHLPlus (EBSCO platform), EMBASE (Ovid platform), SCOPUS and Cochrane databases were searched for studies published between 1 January 2007 and 1 February 2026. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Peer-reviewed primary research studies describing a non-pharmacological intervention with either the intention or effect of reducing MSK fatigue and its impact were included. DATA EXTRACTION AND SYNTHESIS: Title and abstract and subsequent full-text review were performed by two independent reviewers in duplicate. Data were charted in categories according to types of intervention, participant characteristics and theoretical bases. Descriptive analysis of the results is presented.
results337 studies met the criteria. Conditions most frequently studied included fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus. Physical activity was the most common intervention type, most participants were adults and approximately 82% were female. 245 studies reported single component interventions, and 80 included a theoretical basis or the clinical competencies required to deliver them. Common exclusion criteria were physical comorbidities, psychiatric disease or unstable health conditions and cognitive impairments.
conclusionsFew studies have examined how combining single-component interventions can support person-centred fatigue management, and many populations have been excluded from research. To tailor interventions for people with MSK conditions, it is essential to understand how individual characteristics interact with health needs, define the underlying theory, identify the clinical skills required for effective delivery and have more inclusive inclusion criteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.